BioStem Technologies CEO Jason Matuszewski sells $14,300 in common shares
BSEM•BioStem Technologies CEO Jason Matuszewski sold 14,300 shares at $1 each on November 17, leaving him with 1,539,251 shares, according to a Form 4 dated November 19, 2026.



